Markets:

Overview

News

Currencies

International

Treasuries

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

26.18 +0.50 (+1.95%)

Streaming Delayed Price Updated: 10:17 AM EDT, Mar 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PROCEPT BioRobotics Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >

PROCEPT BioRobotics (PRCT) Earnings Transcript ↗

August 06, 2025

Via The Motley Fool

Topics World Trade

PROCEPT BioRobotics Corp. (NASDAQ:PRCT) Reports Q2 2025 Revenue Growth but Misses Profitability Targets, Triggering After-Hours Decline ↗

August 06, 2025

PROCEPT BioRobotics posted strong Q2 2025 revenue growth of 48% YoY but missed profitability estimates, triggering an 8% stock drop. The surgical robotics firm raised full-year guidance but faces...

Via Chartmill

PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

August 06, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Uncovering Potential: PROCEPT BioRobotics's Earnings Preview ↗

August 05, 2025

Via Benzinga

Where PROCEPT BioRobotics Stands With Analysts ↗

April 25, 2025

Via Benzinga

Earnings Scheduled For April 24, 2025 ↗

April 24, 2025

Via Benzinga

4 Analysts Assess PROCEPT BioRobotics: What You Need To Know ↗

February 26, 2025

Via Benzinga

Earnings Scheduled For February 25, 2025 ↗

February 25, 2025

Via Benzinga

PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO

July 24, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy

July 23, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025

July 21, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

How Is The Market Feeling About PROCEPT BioRobotics? ↗

January 24, 2025

Via Benzinga

5 Analysts Assess PROCEPT BioRobotics: What You Need To Know ↗

December 02, 2024

Via Benzinga

Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

July 14, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June

April 29, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops

April 24, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

Looking Into PROCEPT BioRobotics's Recent Short Interest ↗

November 14, 2024

Via Benzinga

The Analyst Landscape: 6 Takes On PROCEPT BioRobotics ↗

November 14, 2024

Via Benzinga

PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

April 24, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

April 10, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation

March 24, 2025

Aquablation therapy delivers similar symptom score reduction, superior ejaculatory function preservation, and superior continence preservation to laser enucleation in 80–180 mL prostates in a...

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada

March 14, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results

February 25, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

February 07, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

Spruce Point Sees Trouble Ahead For Procept BioRobotics ↗

January 16, 2025

Spruce Point Capital warns of Procept BioRobotics' overstated market potential and growth claims, citing niche product limitations and valuation risks.

Via Benzinga

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗

December 02, 2024

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Via Benzinga

This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

December 02, 2024

Via Benzinga

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

November 26, 2024

From PROCEPT BioRobotics

Via GlobeNewswire

Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio? ↗

November 03, 2024

Top mid-cap stock performers: MDGL (+51.70%), PRCT (+34.20%), GSAT (+33.98%), WGS (+31.17%), NXT (+25.91%), VFC (+25.82%), OMCL (+23.22%).

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.